Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: Catechol-O-methyltransferase haplotypes and breast cancer among women on Long Island, New York.

Authors: Gaudet, Mia M; Bensen, Jeannette T; Schroeder, Jane; Olshan, Andrew F; Terry, Mary Beth; Eng, Sybil M; Teitelbaum, Susan L; Britton, Julie A; Lehman, Teresa A; Neugut, Alfred I; Ambrosone, Christine B; Santella, Regina M; Gammon, Marilie D

Published In Breast Cancer Res Treat, (2006 Sep)

Abstract: The gene encoding catechol-O-methyltransferase (COMT), critical to the inactivation of reactive catechol estrogens, has several single nucleotide polymorphisms (SNPs) that influence enzyme activity. A 3-SNP haplotype (IVS1+255 C>T; Ex4-12 G>A; 3'UTR-521 A>G), which has been shown to reduce COMT expression in the human brain, has been identified. To evaluate the influence of genetic variation of COMT on breast cancer risk, these 3-SNPs were genotyped in 1052 cases and 1098 controls. We estimated the associations between breast cancer and individual SNPs, as well as, multilocus haplotypes. We also examined surrogates of hormone exposure as potential modifiers of the putatively functional Ex4-12 SNP-breast cancer association. Odds ratios (OR) and 95% confidence intervals (CI) were based on age-adjusted unconditional logistic regression models. We found no association between the individual SNPs alone and breast cancer. When examining the association between breast cancer and the 3-SNP haplotypes, we observed a 19% increase in risk associated with each copy of the TGG haplotype (OR=1.19, 95% CI 0.96-1.49), relative to the common TAA haplotype, which was statistically significant when assuming a dominant model (OR=1.32, 95% CI 1.05-1.67, p-value=0.02). In this report of COMT haplotypes and breast cancer, we found some evidence that additional genetic variability beyond the Ex4-12 G>A SNP contributes to risk of breast cancer among a small subgroup of women; however, these results need to be replicated in additional studies.

PubMed ID: 16596327 Exiting the NIEHS site

MeSH Terms: Adult; Aged; Breast Neoplasms/enzymology; Breast Neoplasms/epidemiology; Breast Neoplasms/genetics*; Case-Control Studies; Catechol O-Methyltransferase/genetics*; Female; Haplotypes/genetics*; Humans; Middle Aged; New York/epidemiology; Odds Ratio; Polymorphism, Single Nucleotide/genetics*; Risk Factors

Back
to Top